Okyo Pharma Limited ADR (OKYO)
1.4100 x 70 1.4700 x 19
Post-market by (Cboe BZX)
1.4200 +0.0700 (+5.19%) 03/24/25 [NASDAQ]
1.4100 x 70 1.4700 x 19
Post-market 1.4688 +0.0488 (+3.44%) 16:05 ET
for Mon, Mar 24th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2018 | |
| Operating Expenses | 15,750 | 13,187 | 6,218 | 3,366 | 0 |
| Operating Income | -15,750 | -13,187 | -6,218 | -3,366 | N/A |
| Interest Expense | 1,053 | 97 | 0 | 1 | 0 |
| Other Income | 0 | 0 | 0 | -11 | 0 |
| Pre-tax Income | -16,803 | -13,284 | -6,218 | -3,379 | 0 |
| Income Tax | 22 | -12 | -787 | -25 | N/A |
| Net Income Continuous | -16,826 | -13,272 | -5,431 | -3,354 | N/A |
| Net Income | $-16,826 | $-13,272 | $-5,431 | $-3,354 | $N/A |
| EPS Basic Total Ops | -0.57 | -0.61 | -0.36 | -0.65 | N/A |
| EPS Basic Continuous Ops | -0.57 | -0.60 | -0.36 | -0.65 | N/A |
| EPS Diluted Total Ops | -0.57 | -0.61 | -0.36 | -0.65 | N/A |
| EPS Diluted Continuous Ops | -0.57 | -0.60 | -0.36 | -0.65 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.61 | -0.01 | N/A | N/A |
| EBITDA(a) | $-15,746 | $-13,183 | $-6,215 | $-3,365 | $N/A |